BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 28027925)

  • 1. Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome.
    de Cossío LF; Fourrier C; Sauvant J; Everard A; Capuron L; Cani PD; Layé S; Castanon N
    Brain Behav Immun; 2017 Aug; 64():33-49. PubMed ID: 28027925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome.
    Dinel AL; André C; Aubert A; Ferreira G; Layé S; Castanon N
    PLoS One; 2011; 6(9):e24325. PubMed ID: 21949705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice.
    Burokas A; Arboleya S; Moloney RD; Peterson VL; Murphy K; Clarke G; Stanton C; Dinan TG; Cryan JF
    Biol Psychiatry; 2017 Oct; 82(7):472-487. PubMed ID: 28242013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-weaning social isolation of rats leads to long-term disruption of the gut microbiota-immune-brain axis.
    Dunphy-Doherty F; O'Mahony SM; Peterson VL; O'Sullivan O; Crispie F; Cotter PD; Wigmore P; King MV; Cryan JF; Fone KCF
    Brain Behav Immun; 2018 Feb; 68():261-273. PubMed ID: 29104061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapeseed oil fortified with micronutrients improves cognitive alterations associated with metabolic syndrome.
    Fourrier C; Kropp C; Aubert A; Sauvant J; Vaysse C; Chardigny JM; Layé S; Joffre C; Castanon N
    Brain Behav Immun; 2020 Feb; 84():23-35. PubMed ID: 31731013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide-induced brain activation of the indoleamine 2,3-dioxygenase and depressive-like behavior are impaired in a mouse model of metabolic syndrome.
    Dinel AL; André C; Aubert A; Ferreira G; Layé S; Castanon N
    Psychoneuroendocrinology; 2014 Feb; 40():48-59. PubMed ID: 24485475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prebiotics in the management of components of the metabolic syndrome.
    O'Connor S; Chouinard-Castonguay S; Gagnon C; Rudkowska I
    Maturitas; 2017 Oct; 104():11-18. PubMed ID: 28923170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial.
    Ho J; Reimer RA; Doulla M; Huang C
    Trials; 2016 Jul; 17(1):347. PubMed ID: 27456494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prebiotics 3'Sialyllactose and 6'Sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: Evidence for effects on the gut-brain axis.
    Tarr AJ; Galley JD; Fisher SE; Chichlowski M; Berg BM; Bailey MT
    Brain Behav Immun; 2015 Nov; 50():166-177. PubMed ID: 26144888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prebiotic galacto-oligosaccharide on postoperative cognitive dysfunction and neuroinflammation through targeting of the gut-brain axis.
    Yang XD; Wang LK; Wu HY; Jiao L
    BMC Anesthesiol; 2018 Nov; 18(1):177. PubMed ID: 30497394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice.
    Moya-Pérez A; Neef A; Sanz Y
    PLoS One; 2015; 10(7):e0126976. PubMed ID: 26161548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice.
    Savignac HM; Couch Y; Stratford M; Bannerman DM; Tzortzis G; Anthony DC; Burnet PWJ
    Brain Behav Immun; 2016 Feb; 52():120-131. PubMed ID: 26476141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic psychological stress and high-fat high-fructose diet disrupt metabolic and inflammatory gene networks in the brain, liver, and gut and promote behavioral deficits in mice.
    de Sousa Rodrigues ME; Bekhbat M; Houser MC; Chang J; Walker DI; Jones DP; Oller do Nascimento CMP; Barnum CJ; Tansey MG
    Brain Behav Immun; 2017 Jan; 59():158-172. PubMed ID: 27592562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gut microbiota on regulation potential of Dendrobium officinale Kimura & Migo in metabolic syndrome: In-vitro fermentation screening and in-vivo verification in db/db mice.
    Song Q; Cheng SW; Zou J; Li KSL; Cheng H; Wai Lau DT; Han Q; Yang X; Shaw PC; Zuo Z
    J Ethnopharmacol; 2024 Mar; 321():117437. PubMed ID: 37981116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.
    Lambert JE; Parnell JA; Eksteen B; Raman M; Bomhof MR; Rioux KP; Madsen KL; Reimer RA
    BMC Gastroenterol; 2015 Dec; 15():169. PubMed ID: 26635079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.
    O'Donovan AN; Herisson FM; Fouhy F; Ryan PM; Whelan D; Johnson CN; Cluzel G; Ross RP; Stanton C; Caplice NM
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H590-H603. PubMed ID: 32031871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.